MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2018 International Congress

    Screening performance of abbreviated versions of the UPSIT smell test

    T. Joseph, S. Auger, L. Peress, D. Rack, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To compare the screening performance of existing abbreviated (4-12 item) versions of the 40-item University of Pennsylvania Smell Identification Test (UPSIT), and to identify…
  • 2018 International Congress

    Nursing diagnoses, outcomes and ICNP® interventions related to urinary dysfunction in Parkinson’s disease

    M. Tosin, B. Oliveira (Santos-SP, Brazil)

    Objective: To describe the nursing diagnoses, outcomes and interventions related to urinary dysfunction in Parkinson disease. Background: The complexity of motor and nonmotor symptoms in…
  • 2018 International Congress

    The difference in posture reaction against backward perturbation between patients with Parkinson’s disease and healthy controls

    K. Kannari, S. Koseki, C. Narita, S. Sugo. (Aomori, Japan)

    Objective: To investigate the posture reaction in patients with Parkinson’s disease (PD) and healthy age-matched controls when they were given quantitative backward perturbation. Background: Although…
  • 2018 International Congress

    T lymphocytes in Parkinson’s disease pathogenesis and therapy: A systematic review

    J. Baird, J. Quinn (Portland, OR, USA)

    Objective: A systematic literature review was conducted to synthesize the current state of knowledge on the role of T lymphocytes in Parkinson’s disease (PD) pathology…
  • 2018 International Congress

    Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism

    M. Bhargava, S. Bhargava (Kanpur, India)

    Objective: In the present investigation, amino acid coupled liposome bearing dopamine-HCl were prepared to deliver drug to the brain utilizing receptor-mediated transcytosis for effective management…
  • 2018 International Congress

    Personality Traits and Sleep Quality in Parkinson’s disease patients

    JY. Yun, HJ. Kim, HN. Kim, HL. Kim (Seoul, Republic of Korea)

    Objective: To investigate which types of personality traits are related to sleep quality in Parkinson’s disease (PD) patients. Background: Sleep disturbance is a common nonmotor…
  • 2018 International Congress

    Preliminary Results of Psychometric Properties of the Turkish version of Falls Efficacy Scale – International in Patients with Parkinson’s Disease

    F. Nazli, E A. Ozturk, B. Gonenli Kocer, S B. Tonuk, N. Tezel, A. Can, C. Uz, O. Ecerkale, F A. Cakci (Ankara, Turkey)

    Objective: To assess the psychometric properties of the Turkish version of Falls Efficacy Scale - International (FES-I) in Parkinson’s disease (PD) patients. Background: Fear of…
  • 2018 International Congress

    STN deep brain stimulation can directly suppress levodopa-induced dyskinesia in Parkinson’s disease

    J. Li, Y. Zhang (Beijing, China)

    Objective: The study aims to evaluate the effect of bilateral STN-DBS on levodopa-induced peak-dose dyskinesia in patients with PD. Background: Dyskinesia is among the most…
  • 2018 International Congress

    A Real-world Assessment of Hospitalizations Due to Falls among Patients with and without OFF episodes in Parkinson’s Disease

    K. Rajagopalan, A. Lee, J. Barton, J. Pike (Marlborough, MA, USA)

    Objective: To investigate the association between “OFF” episodes and hospitalizations due to falls among patients with Parkinson’s disease (PD) in a real-world setting. Background: Quantitative…
  • 2018 International Congress

    Artisanal formulations of Cannabis in Movement Disorders. The real-life perspective in a population from Buenos Aires, Argentina. Preliminary report

    M. Cesarini, JL. Etcheverry, N. Gonzalez Rojas, G. Da Prat, V. Parisi, G. Rojas, G. Persi, E. Gatto (Buenos Aires, Argentina)

    Objective: To describe the effect of artisanal formulations of CBDo in a retrospective case series of patients with a variable spectrum of movement disorders, who…
  • « Previous Page
  • 1
  • …
  • 243
  • 244
  • 245
  • 246
  • 247
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley